Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation

Transplantation

Volumn 89, Issue 5, 2010, Pages 509-517

  Park, Ki Soo ^a,b   Kim, Young Seok ^a,b   Kim, Jae Hyeon ^b   Choi, Bongkum ^a,b   Kim, Sa Hyun ^b   Tan, Alice Hyun Kyung ^b   Lee, Myung Shik ^b   Lee, Moon Kyu ^b   Kwon, Choon Hyuck ^a   Joh, Jae Won ^a   Kim, Sung Joo ^a,b   Kim, Kwang Won ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Islet culture; Islet transplantation; Mesenchymal stem cells; Trophic effect

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOPOIETIN RECEPTOR; DNA; FOCAL ADHESION KINASE; GLUCOSE; HEAT SHOCK PROTEIN 32; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; SCATTER FACTOR; STREPTOZOCIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; X LINKED INHIBITOR OF APOPTOSIS;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DNA FRAGMENTATION; INSULIN RELEASE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 77949350958     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Goto M, Yoshikawa Y, Matsuo K, et al. Optimization of a prominent oxygen-permeable device for pancreatic islets. Transplant Proc 2008; 40: 411.
2. Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524.
3. Ilieva A, Yuan S, Wang RN, et al. Pancreatic islet cell survival following islet isolation: The role of cellular interactions in the pancreas. J Endo-crinol 1999; 161: 357.
4. Keymeulen B, Gillard P, Mathieu C, et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006; 103: 17444.
5. Ichii H, Sakuma Y, Pileggi A, et al. Shipment of human islets for transplantation. Am J Transplant 2007; 7: 1010.
6. Ling Z, Hannaert JC, Pipeleers D. Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 1994; 37: 15.
7. Woods EJ, Walsh CM, Sidner RA, et al. Improved in vitro function of islets using small intestinal submucosa. Transplant Proc 2004; 36: 1175.
8. Rutzky LP, Bilinski S, Kloc M, et al. Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1. Transplantation 2002; 74: 13.
9. Miki A, Narushima M, Okitsu T, et al. Maintenance of mouse, rat, and pig pancreatic islet functions by coculture with human islet-derived fibroblasts. Cell Transplant 2006; 15: 325.
10. Luo L, Badiavas E, Luo JZ, et al. Allogeneic bone marrow supports human islet beta cell survival and function over six months. Biochem Biophys Res Commun 2007; 361: 859.
11. Granero-Molto F, Weis JA, Longobardi L, et al. Role of mesenchymal stem cells in regenerative medicine: Application to bone and cartilage repair. Expert Opin Biol Ther 2008; 8: 255.
12. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321.
13. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076.
14. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008; 47: 1634.
15. Lataillade JJ, Doucet C, Bey E, et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007; 2: 785.
16. Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchy-mal stem cells resultsin trophic support of cardiac myocytes after myo-cardial infarction. FASEB J 2007; 21: 3197.
17. Park HJ, Lee PH, Bang OY, etal. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008; 107: 141.
18. Choi SE, Choi KM, Yoon IH, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol 2004; 13: 43.
19. Cheng Y, Liu YF, Zhang JL, et al. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J Gastroenterol 2007; 13: 2862.
20. Fiaschi-Taesch NM, Berman DM, Sicari BM, et al. Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets. Diabetes 2008; 57: 2745.
21. Urbán VS, Kiss J, Kovacs J, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008; 26: 244.
22. Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22:625.
23. Gozal E, Ortiz LA, Zou X, et al. Silica-induced apoptosis in murine macrophage: Involvement of tumor necrosis factor-alpha and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 2002; 27: 91.
24. Invernici G, Emanueli C, Madeddu P, et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogen-esis, and myogenesis in vitro and in a murine model of peripheral ischemia. AmJ Pathol 2007; 170: 1879.
25. Boker A, Rothenberg L, Hernandez C, et al. Human islet transplantation: Update. World J Surg 2001; 25: 481.
26. Robertson RP. Islet transplantation as a treatment for diabetes\A work in progress. N Engl J Med 2004; 350: 694.
27. Miwa I, Taniguchi S. Acceleration by fructose of the ATP-sensitive K(+) channel-independent pathway of glucose-induced insulin secretion. Horm Metab Res 2002; 34: 450.
28. McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetolo-gia 2001; 44: 1203.
29. Taniguchi H, Yamato E, Tashiro F, et al. beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas. Gene Ther 2003; 10: 15.
30. Pileggi A, Molano RD, Berney T, et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001; 50: 1983.
31. Lee DY, Lee S, Nam JH, et al. Minimization of immunosuppressive therapy after islet transplantation: Combined action of heme oxygenase-1 and PEGylation to islet. Am J Transplant 2006; 6:1820.
32. Emamaullee JA, Rajotte RV, Liston P, et al. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 2005; 54: 2541.
33. Plesner A, Liston P, Tan R, et al. The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. Diabetes 2005; 54:2533.
34. Aikin R, Hanley S, Maysinger D, et al. Autocrine insulin action activates Akt and increases survival of isolated human islets. Diabetologia 2006; 49:2900.
35. MengZX, Sun JX, Ling JJ, etal. Prostaglandin E2 regulates Foxo activity via the Akt pathway: Implications for pancreatic islet beta cell dysfunction. Diabetologia 2006; 49: 2959.
36. Cross SE, Richards SK, Clark A, et al. Vascular endothelial growth factor as a survival factor for human islets: Effect of immunosuppressive drugs. Diabetologia 2007; 50: 1423.
37. Chae HY, Lee BW, Oh SH, et al. Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice. Exp Mol Med 2005; 37:513.
38. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp CellRes 2006; 312:549.
39. Suzuki Y, Komi Y, Ashino H, et al. Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via sup-pressionofTie2 signaling in vascular progenitor cells. Blood 2004; 104:166.
40. Chong AY, Caine GJ, Lip GY. Angiopoietin/tie-2 as mediators of angiogenesis: A role in congestive heart failure? Eur J Clin Invest 2004; 34:9.
41. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18: 5356.
42. Matsumoto T, Mugishima H. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb 2006; 13: 130.
43. Johansson M, Mattsson G, Andersson A, et al. Islet endothelial cells and pancreatic beta-cell proliferation: Studies in vitro and during pregnancy in adult rats. Endocrinology 2006; 147: 2315.
44. Kutty RK, Nagineni CN, Kutty G, et al. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 1994; 159: 371.
45. Ogawa M, Nishiura T, Oritani K, et al. Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line. Cancer Res 2000; 60:4262.
46. Garcia-Ocana A, Vasavada RC, Cebrian A, et al. Transgenic overexpres-sion of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 2001; 50: 2752.
47. Lin CC, Chiang LL, Lin CH, et al. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur J Pharmacol 2007; 560: 101.